Eton Pharmaceuticals (NASDAQ:ETON) just reported results for the first quarter of 2024.
- Eton Pharmaceuticals reported earnings per share of -3 cents. This was above the analyst estimate for EPS of -7 cents.
- The company reported revenue of $7.97 million.
- This was 4.02% worse than the analyst estimate for revenue of $8.30 million.